NEC Electronics

NEC is a global technology leader that has leveraged its expertise in artificial intelligence and high-performance computing to enter the biotechnology and precision medicine fields. The company's AI Drug Discovery division focuses on developing personalized cancer vaccines and infectious disease treatments by identifying optimal neoantigens through its proprietary NEC Immune Profiler platform. NEC operates through strategic partnerships, most notably with Transgene for the clinical development of the TG4050 vaccine, and through its specialized subsidiary, NEC OncoImmunity. Its approach integrates advanced machine learning with genomic data to create highly targeted, patient-specific immunotherapies. By combining its computational prowess with biological research, NEC aims to significantly reduce the time and cost associated with drug development while improving patient outcomes in oncology.